Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria

Hdl Handle:
http://hdl.handle.net/10144/347156
Title:
Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria
Authors:
Avong, Y K; Isaakidis, P; Hinderaker, S G; Van den Bergh, R; Ali, E; Obembe, B O; Ekong, E; Adebamowo, C; Ndembi, N; Okuma, J; Osakwe, A; Oladimeji, O; Akang, G; Obasanya, J O; Eltayeb, O; Agbaje, A V; Abimiku, A; Mensah, C O; Dakum, P S
Journal:
PLoS One
Abstract:
Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria.
Publisher:
Public Library of Science
Issue Date:
17-Mar-2015
URI:
http://hdl.handle.net/10144/347156
DOI:
10.1371/journal.pone.0120161
PubMed ID:
25781958
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorAvong, Y Ken_GB
dc.contributor.authorIsaakidis, Pen_GB
dc.contributor.authorHinderaker, S Gen_GB
dc.contributor.authorVan den Bergh, Ren_GB
dc.contributor.authorAli, Een_GB
dc.contributor.authorObembe, B Oen_GB
dc.contributor.authorEkong, Een_GB
dc.contributor.authorAdebamowo, Cen_GB
dc.contributor.authorNdembi, Nen_GB
dc.contributor.authorOkuma, Jen_GB
dc.contributor.authorOsakwe, Aen_GB
dc.contributor.authorOladimeji, Oen_GB
dc.contributor.authorAkang, Gen_GB
dc.contributor.authorObasanya, J Oen_GB
dc.contributor.authorEltayeb, Oen_GB
dc.contributor.authorAgbaje, A Ven_GB
dc.contributor.authorAbimiku, Aen_GB
dc.contributor.authorMensah, C Oen_GB
dc.contributor.authorDakum, P Sen_GB
dc.date.accessioned2015-03-26T14:28:57Z-
dc.date.available2015-03-26T14:28:57Z-
dc.date.issued2015-03-17-
dc.identifier.citationDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria. 2015, 10 (3):e0120161 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid25781958-
dc.identifier.doi10.1371/journal.pone.0120161-
dc.identifier.urihttp://hdl.handle.net/10144/347156-
dc.description.abstractAdverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria.en_GB
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeriaen
dc.identifier.journalPLoS Oneen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.